Anita Dushyanth
Stock Analyst at Berenberg
(2.78)
# 1,728
Out of 4,789 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $10.63 | +88.15% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $3.43 | +279.01% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.92 | +62,400.00% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $24.07 | +286.37% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $10.63
Upside: +88.15%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $3.43
Upside: +279.01%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.92
Upside: +62,400.00%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $24.07
Upside: +286.37%